These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 14426018

  • 1. [Inhibition "in vitro" of monoamine oxidase].
    NARANJO R.
    Rev Asoc Medica Mex; 1960 Jun 25; 40():272-9. PubMed ID: 14426018
    [No Abstract] [Full Text] [Related]

  • 2. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
    HORITA A.
    Toxicol Appl Pharmacol; 1961 Jul 25; 3():474-80. PubMed ID: 13715854
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of the in vivo inhibition of brain and liver monoamine oxidase as produced by beta-phenylisopropylhydrazine (PIH) and iproniazid.
    GOGERTY JH, HORITA A.
    J Pharmacol Exp Ther; 1960 Aug 25; 129():357-60. PubMed ID: 13850477
    [No Abstract] [Full Text] [Related]

  • 4. Studies on the active center of monoamine oxidase.
    ZELLER EA.
    Experientia; 1960 Sep 15; 16():399-402. PubMed ID: 13788171
    [No Abstract] [Full Text] [Related]

  • 5. Specific liver and brain monoamine oxidase inhibition by alkyl- and arylalkylhydrazines.
    HORITA A, McGRATH WR.
    Proc Soc Exp Biol Med; 1960 Apr 15; 103():753-7. PubMed ID: 14403108
    [No Abstract] [Full Text] [Related]

  • 6. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
    MUSTAKALLIO KK, LEVONEN E, RAEKALLIO J.
    Science; 1961 Aug 04; 134(3475):344. PubMed ID: 13727138
    [Abstract] [Full Text] [Related]

  • 7. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
    PLETSCHER A.
    Ann N Y Acad Sci; 1959 Sep 17; 80():1039-45. PubMed ID: 14433482
    [No Abstract] [Full Text] [Related]

  • 8. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor.
    ARAI A.
    Jpn J Pharmacol; 1960 Mar 17; 9():159-68. PubMed ID: 13683948
    [No Abstract] [Full Text] [Related]

  • 9. [Pharmacological properties of a new inhibitor of monoamine oxidase: 2-hydrazino-1-phenylpropane].
    GENOVESE E, ARRIGONI-MARTELLI E, FRESIA P.
    Farmaco Sci; 1959 Jul 17; 14():516-26. PubMed ID: 13849925
    [No Abstract] [Full Text] [Related]

  • 10. In vivo monoamine oxidase inhibition measured by potentiation of tryptamine convulsions in rats.
    TEDESCHI DH, TEDESCHI RE, FELLOWS EJ.
    Proc Soc Exp Biol Med; 1960 Apr 17; 103():680-2. PubMed ID: 13837257
    [No Abstract] [Full Text] [Related]

  • 11. Accumulation of serotonin in the brain of reserpine-treated mice after inhibition of monoamine oxidase: effect of body temperature.
    DUBNICK B, LEESON GA, CHESSIN M, SCOTT CC.
    Arch Int Pharmacodyn Ther; 1960 Jun 01; 126():194-202. PubMed ID: 13818306
    [No Abstract] [Full Text] [Related]

  • 12. An in vivo test for measuring monoamine oxidase inhibition in human subjects.
    RESNICK O, HAGOPIAN M, HOAGLAND H, FREEMAN H.
    AMA Arch Gen Psychiatry; 1960 Apr 01; 2():459-61. PubMed ID: 14437446
    [No Abstract] [Full Text] [Related]

  • 13. Reversal of the reserpine-induced depletion of brain serotonin by a monoamine oxidase inhibitor.
    CANAL N, MAFFEI-FACCIOLI A.
    J Neurochem; 1959 Dec 01; 5():99-100. PubMed ID: 13807360
    [No Abstract] [Full Text] [Related]

  • 14. Anticonvulsant properties of monoamine oxidase inhibitors.
    PROCKOP DJ, SHORE PA, BRODIE BB.
    Ann N Y Acad Sci; 1959 Sep 17; 80():643-51. PubMed ID: 14434994
    [No Abstract] [Full Text] [Related]

  • 15. The pharmacological evaluation of monoamine oxidase inhibitors.
    LESSIN AW.
    Biochem Pharmacol; 1959 Nov 17; 2():290-8. PubMed ID: 14416030
    [No Abstract] [Full Text] [Related]

  • 16. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S, SHORE PA, BRODIE BB.
    J Pharmacol Exp Ther; 1960 Jan 17; 128():15-21. PubMed ID: 13833205
    [No Abstract] [Full Text] [Related]

  • 17. [On quantitative differences in the effect between 1-isonicotinoyl-2-isopropyl hydrazine (iproniazid) and isopropyl hydrazine on monoamine oxidase].
    HEIM F, DIEMER K.
    Med Exp Int J Exp Med; 1960 Jan 17; 3():249-51. PubMed ID: 13712856
    [No Abstract] [Full Text] [Related]

  • 18. Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain.
    BRODIE BB, SPECTOR S, SHORE PA.
    Ann N Y Acad Sci; 1959 Sep 17; 80():609-16. PubMed ID: 13804624
    [No Abstract] [Full Text] [Related]

  • 19. Theoretic background of therapy with monoamine oxidase inhibitors in cardiology.
    ZBINDEN G.
    Am J Cardiol; 1960 Dec 17; 6():1121-4. PubMed ID: 13788034
    [No Abstract] [Full Text] [Related]

  • 20. [EFFECT OF ALPHA-SUBSTITUTED BETA-(2-METHYL-3-INDOLYL)-PROPIONIC ACID HYDRAZIDES ON THE ACTIVITY OF BRAIN MONOAMINO OXIDASES].
    SAFRAZBEKIAN RR, SUKASIAN RS.
    Farmakol Toksikol; 1964 Dec 17; 27():213-7. PubMed ID: 14193091
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.